Virtuix (VTIX) investor relations material

Market overview and technology highlights

• AI-driven full-body VR systems target consumer, enterprise, healthcare, and defense sectors.

• Core product, Omni, is an omnidirectional treadmill enabling immersive movement in virtual environments.

• Strong IP portfolio with 25 issued patents, one recently allowed, and five pending.

• Production facility can manufacture 3,000 Omni One units monthly, supporting up to $100M annual revenue.

• AI-powered 3D reconstruction creates virtual replicas of real-world locations rapidly for various applications.

Consumer market developments

• Partnership with Meta launched Omni One for Quest, compatible with Quest 2 and 3 headsets.

• Addressable market expanded by 6 million active Quest users; sales exceeding expectations.

• Product offers fitness benefits, burning up to 700 calories per hour; some users report significant weight loss.

• DTC business model with $2,500 price point and financing options; targets 40% gross margin.

• Recurring revenue streams from software, game sales, and online subscriptions.

Enterprise and medical applications

• AI-driven 3D reconstruction enables rapid creation of virtual environments for training and simulation.

• Applications include industrial safety, robotics, and medical rehabilitation, such as autism therapy and stroke recovery.

• Partnerships with Sirica Therapeutics, Rutgers University, and Florida Gulf Coast University for healthcare initiatives.

• Medical field seen as a potential major market, with thousands of therapy centers as prospective customers.

• VR therapy already reimbursed in some cases; collaborations with major headset manufacturers.